表紙:核医学の世界市場 - 市場規模・シェア・動向分析:製品別、治療法別、用途別、地域別、セグメント別の予測(2022年~2030年)
市場調査レポート
商品コード
1076668

核医学の世界市場 - 市場規模・シェア・動向分析:製品別、治療法別、用途別、地域別、セグメント別の予測(2022年~2030年)

Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET)), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy), By Application, By Region, And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 165 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
核医学の世界市場 - 市場規模・シェア・動向分析:製品別、治療法別、用途別、地域別、セグメント別の予測(2022年~2030年)
出版日: 2022年04月28日
発行: Grand View Research, Inc.
ページ情報: 英文 165 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の核医学の市場規模は、2030年までに244億米ドルに達し、2022年~2030年にCAGRで13.0%の成長が予測されています。

癌や甲状腺疾患などの慢性疾患の増加のほか、予測期間中に複数の放射性医薬品治療法の承認が差し迫っていることが、市場の主要な促進要因になると予想されています。

当レポートでは、世界の核医学市場について調査分析し、業界の見通し、製品・用途・地域別の動向分析、競合分析などを提供しています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 市場の定義

第4章 業界の見通し

  • 市場変数分析
    • 癌と心血管疾患の発生率の上昇
    • 放射性医薬品/核医学の適用の増加
    • 正確な診断方法に対する需要の高まり
    • 市場抑制要因分析
    • SWOT分析:要因別(政治的・法的・経済的・技術的)
    • ポーターのファイブフォース分析
    • バリューチェーン分析
  • 要因/規制のリスト:国別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 生産プロセスと動向
    • モリブデン-99(SPECT放射性同位体)の製造
    • SPECT放射性同位体の動向
    • PET放射性同位体の動向
    • 治療用放射性同位体の動向
  • 放射性医薬品市場 - COVID-19の影響
  • パイプライン分析

第5章 競合分析

  • ベンダー情勢
    • 主要な販売業者とチャネルパートナーのリスト
  • 公開会社
    • 企業市況分析
    • 競合ダッシュボード分析
  • 非公開会社
    • 主要な新興企業/テクノロジーディスラプター/イノベーターのリスト
    • 地域ネットワークマップ

第6章 事業分析:製品別

  • 放射性医薬品市場:動向分析、製品別
  • 診断用製品
  • 治療用製品

第7章 事業分析:用途別

  • 放射性医薬品:動向分析、用途別

第8章 事業分析:地域別

  • 放射性医薬品市場:動向分析、地域別
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 企業プロファイル

  • ECKERT & ZIEGLER
  • MALLINCKRODT
  • CURIUM PHARMA
  • GENERAL ELECTRIC
  • JUBILANT LIFE SCIENCES LTD.
  • BRACCO IMAGING S.P.A.
  • NORDION(CANADA), INC.
  • THE INSTITUTE FOR RADIOELEMENTS(IRE-IRE ELIT-BE)
  • AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANIZATION(ANSTO)
  • NTP RADIOISOTOPES SOC LTD.
  • ECZACIBASI-MONROL
  • LANTHEUS MEDICAL IMAGING, INC.
図表

List of Tables

  • Table 1 Global Nuclear Medicine Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 3 Global Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 4 North America Nuclear Medicine Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 North America Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 U.S. Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 Canada Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Canada Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 12 Europe Nuclear Medicine Market, By Region, 2018 - 2030 (USD Million)
  • Table 13 Europe Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 Europe Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 15 U.K. Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 U.K. Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Germany Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 Germany Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 19 France Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 France Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Italy Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 Italy Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 Spain Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Spain Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 25 Russia Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Russia Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific Nuclear Medicine Market, By Region, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Japan Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Japan Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 China Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 China Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 34 India Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 35 India Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Australia Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 37 Australia Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Singapore Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 Singapore Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 South Korea Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 South Korea Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Latin America Nuclear Medicine Market, By Region, 2018 - 2030 (USD Million)
  • Table 43 Latin America Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 44 Latin America Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Brazil Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Brazil Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 47 Mexico Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 48 Mexico Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Argentina Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 50 Argentina Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa Nuclear Medicine Market, By Region, 2018 - 2030 (USD Million)
  • Table 52 Middle East & Africa Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 South Africa Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 55 South Africa Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 UAE Nuclear Medicine Market, By Product, 2018 - 2030 (USD Million)
  • Table 59 UAE Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Radiopharmaceuticals market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Nuclear Medicine market snapshot
  • Fig. 10 Nuclear Medicine market driver impact
  • Fig. 11 Global cancer cases projection,s-2030 (Number of new registered cases)
  • Fig. 12 Nuclear Medicine market restraint impact
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Value chain analysis
  • Fig. 16 Nuclear Medicine Market: Production of Tc-99 (SPECT radioisotopes)
  • Fig. 17 Nuclear Medicine market: Production of 18F-FDG (PET radioisotopes)
  • FIG.18 Company market share analysis
  • Fig. 19 Company market position analysis
  • Fig. 20 Company market position analysis
  • Fig. 21 Competitive dashboard analysis
  • Fig. 22 Regional network map
  • Fig. 23 Nuclear Medicine market: Product outlook and key takeaways
  • Fig. 24 Nuclear Medicine market: Product movement analysis
  • Fig. 25 Diagnostic products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 SPECT products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 TC-99m market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 TL-201 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 GA-67 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 I-123 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Other SPECT products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 PET products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 F-18 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 SR-82/RB-82 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Other PET products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Therapeutic products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Alpha emitters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 RA-223 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Beta emitters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 I-131 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Y-90 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 SM-153 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Re-186 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Lu-177 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Other beta emitters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Brachytherapy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Cesium-131 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Iodine-125 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Palladium-103 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Iridium-192 market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Other brachytherapy products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Nuclear Medicine market: Application outlook and key takeaways
  • Fig. 53 Nuclear Medicine market: Application movement analysis
  • Fig. 54 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Thyroid market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Lymphoma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Bone metastasis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Endocrine tumor market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Nuclear Medicine market: Regional outlook and key takeaways
  • Fig. 63 Nuclear Medicine market: Regional movement analysis
  • Fig. 64 North America
  • Fig. 65 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 U.S.
  • Fig. 67 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Canada
  • Fig. 69 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Europe
  • Fig. 71 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 U.K.
  • Fig. 73 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Germany
  • Fig. 75 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Italy
  • Fig. 77 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Spain
  • Fig. 79 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 France
  • Fig. 81 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Russia
  • Fig. 83 Russia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Asia Pacific
  • Fig. 85 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Japan
  • Fig. 87 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 China
  • Fig. 89 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 India
  • Fig. 91 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Singapore
  • Fig. 92 Singapore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Australia
  • Fig. 94 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 South Korea
  • Fig. 96 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America
  • Fig. 98 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil
  • Fig. 100 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Mexico
  • Fig. 102 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Argentina
  • Fig. 104 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Middle East & Africa
  • Fig. 106 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 South Africa
  • Fig. 108 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Saudi Arabia
  • Fig. 110 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 UAE
  • Fig. 112 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Company Profiles
目次
Product Code: GVR-1-68038-086-6

Nuclear Medicine Market Growth & Trends:

The global nuclear medicine market size is expected to reach USD 24.4 billion by 2030, expanding at a CAGR of 13.0% from 2022 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer & thyroid is anticipated to drive market growth. The impending approval of multiple radiopharmaceutical therapeutics during the forecast period will be a major driver for the market. For instance, in March 2022, Novartis AG received approval for Pluvicto (Lu 177) for the treatment of adult patients with prostate cancer.

According to the Pan American Health Organization (PAHO), in 2022, globally around 20 million new cases of cancer are estimated to be diagnosed, and around 10 million deaths occurred due to this disease. Factors like changing lifestyle, unhealthy diet, and less awareness about oral hygiene in low and middle-income countries is the most common cause of the prevalence of cancer.

Increasing adoption of nuclear medicine products in diagnosis and the approval of new generators to help increase the supply of radionuclides is expected to drive growth. For instance, in November 2021, EZAG received the Brazilian Health Authority Regulatory Agency's (ANVISA) approval for GalliaPharm in Brazil. It is a gallium-68 generator used to extract the positron-emitting isotope of gallium from a source of decaying germanium-68 for making G68 dotatate injection. This is the first and only gallium generator approved for pharmaceutical use in Brazil. The approval of such products contributes to the market growth in developing markets.

In light of the COVID-19 pandemic, the market was moderately impacted. A survey was conducted for reactor-based medical isotopes by International Atomic Energy Agency (IAEA) during the second quarter of 2020 to assess the continuity of the supply chain during the COVID-19 crisis. It was revealed that major producers continued with production in line with IAEA safety standards, as their operations were categorized as essential by their respective governments.

Nuclear Medicine Market Report Highlights:

  • By product type, the SPECT segment held the largest share of the diagnostics market due to low cost, high accuracy, and wide usage in different applications
  • The PET segment is expected to grow lucratively over the forecast period due to the approval & launch of new products such as PYLARIFY PET imaging agent for prostate cancer
  • By application, the oncology segment dominated the market in 2021 with a share of 42.06%
  • North America dominated the global market in 2021, owing to increased awareness about current treatment therapies, favorable reimbursement policies, and improved patient affordability.
  • The Asia Pacific region is expected to grow considerably in the future due to the rising prevalence of chronic diseases, rising geriatric population, and approval of new products during the forecast period.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Definitions

Chapter 4 Industry Outlook

  • 4.1 Market Variable Analysis
    • 4.1.1 Rising Incidence Of Cancer And Cardiovascular Diseases
    • 4.1.2 Increasing Application Of Radiopharmaceuticals/Nuclear Medicine
    • 4.1.3 Growing Demand For Accurate Diagnostic Methods
    • 4.1.4 Market Restraint Analysis
      • 4.1.4.1 Stringent Regulations Pertaining To Production, Storage, & Usage
      • 4.1.4.2 High Costs Associated With Diagnostics & Therapeutic Procedures
    • 4.1.5 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
    • 4.1.6 Porter's Five Forces Analysis
    • 4.1.7 Value Chain Analysis
  • 4.2 List Of Factors/Regulations By Country
    • 4.2.1 North America
      • 4.2.1.1 U.S.
      • 4.2.1.2 Canada
    • 4.2.2 Europe
    • 4.2.3 Asia Pacific
      • 4.2.3.1 China
      • 4.2.3.2 Japan
      • 4.2.3.3 India
      • 4.2.3.4 Australia/New Zealand
      • 4.2.3.5 South Korea
      • 4.2.3.6 Singapore
      • 4.2.3.7 Malaysia
      • 4.2.3.8 Philippines
    • 4.2.4 Latin America
      • 4.2.4.1 Brazil
      • 4.2.4.2 Mexico
      • 4.2.4.3 Argentina
    • 4.2.5 Middle East & Africa
      • 4.2.5.1 South Africa
      • 4.2.5.2 Gcc
  • 4.3 Production Process And Trends
    • 4.3.1 Production Of Molybdenum-99 (Spect Radioisotopes)
    • 4.3.2 Spect Radioisotopes Trends
    • 4.3.3 Pet Radioisotopes Trends
      • 4.3.3.1 Production Of Pet Radioisotopes
    • 4.3.4 Therapeutic Radioisotopes Trends
      • 4.3.4.1 Production Process And Trends
  • 4.4 Radiopharmaceuticals Market - Covid-19 Impact
  • 4.5 Pipeline Analysis

Chapter 5 Competitive Analysis

  • 5.1 Vendor Landscape
    • 5.1.1 List Of Key Distributors And Channel Partners
    • 5.1.2 Key Company Market Share Analysis, 2021
  • 5.2 Public Companies
    • 5.2.1 Company Market Position Analysis
    • 5.2.2 Competitive Dashboard Analysis
  • 5.3 Private Companies
    • 5.3.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 5.3.2 Regional Network Map

Chapter 6 Product Business Analysis

  • 6.1 Radiopharmaceuticals Market: Product Movement Analysis
  • 6.2 Diagnostic Products
    • 6.2.1 Diagnostic Products Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.1 Spect
      • 6.2.1.1.1 Spect Products Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.1.2 Tc-99m
      • 6.2.1.1.3 Tc-99m Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.1.4 Tl-201
      • 6.2.1.1.5 Tl-201 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.1.6 Ga-67
      • 6.2.1.1.7 Ga-67 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.1.8 I-123
      • 6.2.1.1.9 I-123 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.1.10 Other Spect Products
      • 6.2.1.1.11 Other Spect Products Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.2 Pet
      • 6.2.1.2.1 Pet Products Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.2.2 F-18
      • 6.2.1.2.3 F-18 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.2.4 Sr-82/Rb-82
      • 6.2.1.2.5 Sr-82/Rb-82 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.1.2.6 Other Pet Products
      • 6.2.1.2.7 Other Pet Products Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Therapeutic Products
    • 6.3.1 Therapeutic Products Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Alpha Emitters
      • 6.3.2.1 Alpha Emitters Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.1.1 Ra-223
      • 6.3.2.1.1.1 Ra-223 Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.3 Beta Emitters
      • 6.3.3.1 Beta Emitters Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.3.2 I-131
      • 6.3.3.2.1 I-131 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.3.3 Y-90
      • 6.3.3.3.1 Y-90 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.3.4 Sm-153
      • 6.3.3.4.1 Sm-153 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.3.5 Re-186
      • 6.3.3.5.1 Re-186 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.3.6 Lu-177
      • 6.3.3.6.1 Lu-177 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.3.7 Other Beta Emitters
      • 6.3.3.7.1 Other Beta Emitters Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.4 Brachytherapy
      • 6.3.4.1 Brachytherapy Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.4.2 Cesium-131
      • 6.3.4.2.1 Cesium-131 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.4.3 Iodine-125
      • 6.3.4.3.1 Iodine-125 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.4.4 Palladium-103
      • 6.3.4.4.1 Palladium-103 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.4.5 Iridium-192
      • 6.3.4.5.1 Iridium-192 Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.4.6 Other Brachytherapy Products
      • 6.3.4.6.1 Other Brachytherapy Products Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Application Mode Business Analysis

  • 7.1 Radiopharmaceuticals: Application Movement Analysis
    • 7.1.1 Cardiology
      • 7.1.1.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.1.2 Neurology
      • 7.1.2.1 Neurology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.1.3 Oncology
      • 7.1.3.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.1.4 Thyroid
      • 7.1.4.1 Thyroid Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.1.5 Lymphoma
      • 7.1.5.1 Lymphoma Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.1.6 Bone Metastasis
      • 7.1.6.1 Bone Metastasis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.1.7 Endocrine Tumor
      • 7.1.7.1 Endocrine Tumor Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.1.8 Other Application
      • 7.1.8.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Regional Business Analysis

  • 8.1 Radiopharmaceuticals Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 U.K.
      • 8.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Italy
      • 8.3.4.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 Spain
      • 8.3.5.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 France
      • 8.3.6.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.7 Russia
      • 8.3.7.1 Russia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 Singapore
      • 8.4.5.1 Singapore Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.7 South Korea
      • 8.4.7.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa
    • 8.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudia Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.4 Uae
      • 8.6.4.1 Uae Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Company Profiles

  • 9.1 ECKERT & ZIEGLER
    • 9.1.1 Company overview
    • 9.1.2 Financial performance
    • 9.1.3 Product benchmarking
    • 9.1.4 Strategic initiatives
  • 9.2 MALLINCKRODT
    • 9.2.1 Company overview
  • 9.3 CURIUM PHARMA
    • 9.3.1 Company overview
    • 9.3.2 Product benchmarking
    • 9.3.3 Strategic initiatives
  • 9.4 GENERAL ELECTRIC
    • 9.4.1 Company overview
    • 9.4.2 Financial performance
    • 9.4.3 Product benchmarking
    • 9.4.4 Strategic initiatives
  • 9.5 JUBILANT LIFE SCIENCES LTD.
    • 9.5.1 Company overview
    • 9.5.2 Financial performance
    • 9.5.3 Product benchmarking
    • 9.5.4 Strategic initiatives
  • 9.6 BRACCO IMAGING S.P.A.
    • 9.6.1 Company overview
    • 9.6.2 Product benchmarking
    • 9.6.3 Strategic initiatives
  • 9.7 NORDION (CANADA), INC.
    • 9.7.1 Company overview
    • 9.7.2 Product benchmarking
    • 9.7.3 Strategic initiatives
  • 9.8 THE INSTITUTE FOR RADIOELEMENTS (IRE - IRE ELIT - BE)
    • 9.8.1 Company overview
    • 9.8.2 Product benchmarking
    • 9.8.3 Strategic initiatives
  • 9.9 AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANIZATION (ANSTO)
    • 9.9.1 Company overview
    • 9.9.2 Financial performance
    • 9.9.3 Product benchmarking
    • 9.9.4 Strategic initiatives
  • 9.10 NTP RADIOISOTOPES SOC LTD.
    • 9.10.1 Company overview
    • 9.10.2 Financial performance
    • 9.10.3 Product benchmarking
    • 9.10.4 Strategic initiatives
  • 9.11 ECZACIBASI-MONROL
    • 9.11.1 Company overview
    • 9.11.2 Financial performance
    • 9.11.3 Product benchmarking
    • 9.11.4 Strategic initiatives
  • 9.12 LANTHEUS MEDICAL IMAGING, INC.
    • 9.12.1 Company overview
    • 9.12.2 Financial overview
    • 9.12.3 Product benchmarking
    • 9.12.4 Strategic initiatives